USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Inovio Pharmaceuticals, Inc.
Address:
11494 Sorrento Valley Road
Suite A
San Diego, CA
Phone:
N/A
URL:
EIN:
330969592
DUNS:
879167674
Number of Employees:
42
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $69,670.00 1
SBIR Phase II $765,261.00 1

Award List:

Multiagent Synthetic DNA Vaccines Delivered by Noninvasive Electroporation

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$69,670.00
Agency:
DOD
Principal Investigator:
Kate Broderick, Associate Director, R&D – (858) 410-3161
Abstract:
Inovio Pharmaceuticals current minimally invasive dermal electroporation prototype device, which uses low voltage parameters to achieve both high and consistent levels of immunogenicity, offers an attractive option as an efficient and tolerable method for delivering DNA vaccinations in a clinical… More

Multiagent Synthetic DNA Vaccines Delivered by Noninvasive Electroporation

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$765,261.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Kate Broderick, Director, R&D – (858) 410-3161
Abstract:
The identification of an effective and tolerable delivery method is a necessity for the success of DNA vaccines in the clinic. The objective of this proposal is to continue the development of the effective, tolerable, multi-agent DNA vaccine dermal electroporation device, validate this device and… More